-transparent.png){kind=logo}
Trimelamol is an analogue of hexamethymelamine which exhibited activity against refractory ovarian cancer in phase I clinical trial. The dose limiting toxicity was leukopenia. In a phase II study, 42 patients with recurrent, or platinum-complex resistant, advanced ovarian cancer were treated using the dose schedule 800 mg m-2 i.v. daily for 3 days. There were one complete, three partial and five minor responses, objective response rate: 9.5%. The main toxicity observed was nausea and vomiting, myelosuppression was minor. The role of Trimelamol in the treatment of ovarian cancer remains to be defined, but its activity is limited in refractory disease.
Related Publications
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
May 1986,
Gynecologic oncology,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
January 1986,
Gynecologic oncology,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
June 1994,
American journal of obstetrics and gynecology,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
January 1990,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
November 1994,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
May 2002,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
May 1984,
Cancer treatment reports,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
October 1984,
Cancer treatment reports,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
June 2000,
Gynecologic oncology,
I R Judson, and
A H Calvert, and
M E Gore, and
K Balmanno, and
L A Gumbrell, and
T Perren, and
E Wiltshaw
February 1982,
Cancer treatment reports,
